JW Life Science Corp banner

JW Life Science Corp
KRX:234080

Watchlist Manager
JW Life Science Corp Logo
JW Life Science Corp
KRX:234080
Watchlist
Price: 11 110 KRW -1.33% Market Closed
Market Cap: ₩175.9B

Intrinsic Value

The intrinsic value for JW Life Science Corp (234080) under the Base Case is 17 663.52 KRW. Compared with the current market price of 11 110 KRW, the stock appears Undervalued by 37% .

Intrinsic value calculated as an equal blend of DCF
₩18 695.87
and Multiples
₩16 631.16
Other reference points

Do our valuations actually work? See backtest results .

Intrinsic Value
17 663.52
Undervaluation 37%
Intrinsic Value
Price ₩11 110
Monitor JW Life Science Corp
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ₩14 130.81
Get notified when the price drops into your buy zone
Intrinsic Value ₩17 663.52
Margin of Safety 20% ₩14 130.81
Current Price ₩11 110
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about JW Life Science Corp?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is JW Life Science Corp valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for JW Life Science Corp.

Explain Valuation
Alternatives to JW Life Science Corp

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one JW Life Science Corp stock?

The intrinsic value for JW Life Science Corp (234080) under the Base Case is 17 663.52 KRW.

Is JW Life Science Corp stock undervalued or overvalued?

Compared with the current market price of 11 110 KRW, the stock appears Undervalued by 37% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett